Skip to main content
Clinical Trials/NCT04064177
NCT04064177
Recruiting
Not Applicable

Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study

Imperial College Healthcare NHS Trust1 site in 1 country148 target enrollmentOctober 24, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Output, Low
Sponsor
Imperial College Healthcare NHS Trust
Enrollment
148
Locations
1
Primary Endpoint
Changes in cardiac output
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This is an observational study in newborn term and preterm infants. The study will validate if non-invasive continuous cardiac output monitoring is feasible in newborn infants, if normative values can be constructed and what is the effect of fluid boluses and inotropes on cardiac output and peripheral vascular resistance.

Detailed Description

This is a 3-year prospective observational study. Principal research question: Is non-invasive continuous cardiac output (CO) measurement a validated tool of comprehensive cardiovascular assessment in neonatal intensive care (NICU)? Secondary research questions: 1. Can robust normal ranges of CO be constructed for neonates undergoing cardiovascular measurement? 2. How do neonatal interventions (fluid boluses, ventilation and inotropes) affect CO? 3. Does the Non-invasive continuous cardiac output monitoring in children with foetal growth restriction (FGR) differ from normative CO data as above (1)? A prospective study of stable newborn babies in the postnatal ward and sick term and preterm infants in the NICU in 36 months.

Registry
clinicaltrials.gov
Start Date
October 24, 2019
End Date
December 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy term infants in postnatal ward (within the first 72 hours of age)
  • Term and Preterm infants (including those with FGR) admitted to the neonatal unit
  • Written informed parental consent (prospective for postnatal ward and retrospective for babies admitted to the neonatal units)

Exclusion Criteria

  • Antenatal or postnatal diagnosis of severe congenital anomaly
  • Infants with no realistic chance of survival
  • Infants who are \>12 hours of age
  • Infants with fragile skin not permitting skin probe placement

Outcomes

Primary Outcomes

Changes in cardiac output

Time Frame: 36 months

Changes in cardiac output (CO) measurement (mls/kg/min) in relation to neonatal intervention

Haemodynamic outcome comparison to echocardiography measured CO

Time Frame: 36 months

Non-invasive continuous Cardiac Output (CO) measurement (mls/kg/min) during the first month of life in comparison to echocardiography measured CO (mls/kg/min)

Secondary Outcomes

  • Changes in clinical outcome - Survival at discharge(36 months)

Study Sites (1)

Loading locations...

Similar Trials